Coronary revascularization is not synonymous with myocardial reperfusion. DeWood et al. 1
almost three decades ago showed that 90% of patients with transmural myocardial infarction …

Background The benefits of thrombolytic therapy for acute myocardial infarction (AMI) are
limited by reocclusion of the infarct-related artery, which occurs in 25% to 30% of patients …

Objective: To report one year results of the MERLIN (Middlesbrough early revascularisation
to limit infarction) trial, a prospective randomised trial comparing the strategy of coronary …

Most cases of acute myocardial infarction are caused by disruption of an atherosclerotic
plaque followed by coronary thrombosis (1). In ST-elevation myocardial infarction (STEMI) …

Objectives: This study investigated the relationship between time to invasive assessment
and outcomes among ST-segment elevation myocardial infarction patients randomized to …

OBJECTIVES.: This study attempted to determine which lesion characteristics are
associated with reocclusion by 18 to 36 h. BACKGROUND.: Reocclusion of the infarct …

Objectives. This study sought to readdress the definition of uncomplicated myocardial
infarction and to apply clinical criteria for early discharge of such patients in the thrombolytic …

Abstract The Global Utilization of Streptokinase and Tissue Plasminogen Activator for
Occluded Coronary Arteries (GUSTO) trial is a large scale international trial of new …

OBJECTIVES The study evaluated the efficacy and safety of a short-acting reduced-dose
fibrinolytic regimen to promote early infarct-related artery (IRA) patency during the inherent …

Objectives. The purpose of this study was to determine whether early qualitative or
quantitative angiographic features can predict reocclusion after initially successful coronary …